World Health Organization. Adherence to long-term therapies: Evidence for action, Swizerland: WHO Library Cataloguing-in-Publication Data, 2003.
2.
VermeireEHearnshawHVan RoyenP. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther2001; 26: 331–342.
3.
SantoKKirkendallSLabaTL. Interventions to improve medication adherence in coronary disease patients: a systematic review and meta-analysis of randomized controlled trials. Eur J Prev Cardiol2016; 23: 1065–1076.
4.
DuLDongPJiaJ. Impacts of intensive follow-up on the long-term prognosis of percutaneous coronary intervention in acute coronary syndrome patients – a single center prospective randomized controlled study in a Chinese population. Eur J Prev Cardiol2016; 23: 1077–1085.
5.
FurnissDBarberNLyonsI. Unintentional non-adherence: can a spoon full of resilience help the medicine go down?BMJ Qual Saf2014; 23: 95–98.
6.
KhonsariSSubramanianPChinnaK. Effect of a reminder system using an automated short message service on medication adherence following acute coronary syndrome. Eur J Cardiovasc Nurs2015; 14: 170–179.
7.
AllonenJNieminenMSLokkiM. Mortality rate increases steeply with nonadherence to statin therapy in patients with acute coronary syndrome. Clin Cardiol2012; 35: E22–E27.
8.
OsterbergLBlaschkeT. Adherence to medication. N Engl J Med2005; 353: 487–497.
9.
KhanMUShahSHameedT. Barriers to and determinants of medication adherence among hypertensive patients attended National Health Service Hospital, Sunderland. J Pharm Bioallied Sci2014; 6: 104–108.
10.
KjeldsenLJBjerrumLHerborgH. Development of new concepts of non-adherence measurements among users of antihypertensives medicines. Int J Clin Pharm2011; 33: 565–572.
11.
Lopez-CarmonaDBernal-LopezMRMancera-RomeroJ. Compliance with cardiovascular drug prevention measures in a general population: the Multidisciplinary Intervention in Primary Care (IMAP) study. Eur J Prev Cardiol2012; 19: 1074–1081.
12.
ElliottRABoydMJSalemaNE. Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomized controlled trial of the New Medicine Service. BMJ Qual Saf2016; 25: 747–758.
